Login / Signup

Long-term treatment of hereditary transthyretin amyloidosis with patisiran: multicentre, real-world experience in Italy.

Luca GentileAnna MazzeoChiara BrianiSilvia CasagrandeMarcella De LucaGian Maria FabriziChristian GagliardiChiara GemelliFrancesca ForcinaMarina GrandisValeria GuglielminoGiacomo IabichellaLuca LeonardiAlessandro LozzaFiore ManganelliRoberta MussinelliFilomena MyGiuseppe OcchipintiSilvia FenuMassimo RussoAngela RomanoAlessandro SalvalaggioMatteo TagliapietraStefano TozzaGiovanni PalladiniLaura ObiciMarco Luigetti
Published in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2024)
Patisiran largely stabilised disease in patients with ATTRv amyloidosis.
Keyphrases
  • multiple myeloma
  • clinical trial
  • cross sectional
  • randomized controlled trial
  • replacement therapy